160
Views
5
CrossRef citations to date
0
Altmetric
Research Articles

‘Transfersome-embedded-gel’ for dual-mechanistic delivery of anti-psoriatic drugs to dermal lymphocytes

, , ORCID Icon, , , , & ORCID Icon show all
Pages 495-511 | Received 03 Nov 2021, Accepted 18 Aug 2022, Published online: 02 Sep 2022

References

  • Abd, E., Roberts, M.S., and Grice, J.E., 2016. A comparison of the penetration and permeation of caffeine into and through human epidermis after application in various vesicle formulations. Skin pharmacology and physiology, 29 (1), 24–30.
  • Ahad, A., Aqil, M., and Ali, A., 2014. Investigation of antihypertensive activity of carbopol valsartan transdermal gel containing 1, 8-cineole. International journal of biological macromolecules, 64, 144–149.
  • Ahad, A., et al., 2017. Pharmacodynamic study of eprosartan mesylate-loaded transfersomes Carbopol® gel under Dermaroller® on rats with methyl prednisolone acetate-induced hypertension. Biomedicine & pharmacotherapy biomedecine & pharmacotherapie, 89, 177–184.
  • Al‐Hammadi, A., et al., 2021. Intermittent use of biologic agents for the treatment of psoriasis in adults. Journal of the European academy of dermatology and venereology, 35 (2), 360–367.
  • Al-Suwayeh, S.A., et al., 2014. Evaluation of skin permeation and analgesic activity effects of carbopol lornoxicam topical gels containing penetration enhancer. Scientific world journal, 2014, 1–9.
  • Alomrani, A.H., et al., 2014. Itraconazole-hydroxypropyl-β-cyclodextrin loaded deformable liposomes: in vitro skin penetration studies and antifungal efficacy using Candida albicans as model. Colloids and surfaces B: Biointerfaces, 121, 74–81.
  • Borba, P.A.A., et al., 2014. Pharmaceutical approaches involving carvedilol characterization, compatibility with different excipients and kinetic studies. Journal of thermal analysis and calorimetry, 115 (3), 2507–2515.
  • Boulmedarat, L.L., et al., 2003. Influence of methyl-β-cyclodextrin and liposomes on rheological properties of Carbopol® 974P NF gels. International journal of pharmaceutics, 254 (1), 59–64.
  • Cai, Y., et al., 2012. New insights of T cells in the pathogenesis of psoriasis. Cellular & molecular immunology, 9 (4), 302–309.
  • Carreras, J.J., et al., 2020. Ultraflexible lipid vesicles allow topical absorption of cyclosporin A. Drug delivery and translational research, 10 (2), 486–497.
  • Cauzzo, J., et al., 2020. Following the fate of dye-containing liposomes in vitro. International journal of molecular sciences, 21, 4847.
  • Chen, M., et al., 2015a. Topical delivery of Cyclosporine A into the skin using SPACE-peptide. Journal of controlled release, 199, 190–197.
  • Chen, S., Einspanier, R., and Schoen, J., 2015b. Transepithelial electrical resistance (TEER): a functional parameter to monitor the quality of oviduct epithelial cells cultured on filter supports. Histochemistry and cell biology, 144 (5), 509–515.
  • Conrotto, D., et al., 2006. Ciclosporin vs. clobetasol in the topical management of atrophic and erosive oral lichen planus: a double‐blind, randomized controlled trial. British journal of dermatology, 154 (1), 139–145.
  • Dremin, V. V., et al., 2018. Peculiarities of local blood microcirculation in patients with psoriasis. Proc. SPIE 10685, Biophotonics: Photonic Solutions for Better Health Care VI, 17 May 2018, France, 1068532.
  • Elston, D.M., 2021. American Academy of Dermatology and National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis. Journal of the American academy of dermatology, 84 (2), 257–258.
  • Foroozandeh, P., and Aziz, A.A., 2018. Insight into cellular uptake and intracellular trafficking of nanoparticles. Nanoscale research letters, 13 (1), 339.
  • Ghanbarzadeh, S., and Arami, S., 2013. Enhanced transdermal delivery of diclofenac sodium via conventional liposomes, ethosomes, and transfersomes. BioMed research international, 2013, 1–7.
  • Griffiths, C., et al., 1987. Comparison of psoriasis treated with cyclosporin alone or cyclosporin and clobetasol propionate. British journal of dermatology, 117 (s32), 35–36.
  • Griffiths, C., et al., 2018. A multidimensional assessment of the burden of psoriasis: results from a multinational dermatologist and patient survey. British journal of dermatology, 179 (1), 173–181.
  • Hermans, K., et al., 2012. Full factorial design, physicochemical characterisation and biological assessment of cyclosporine A loaded cationic nanoparticles. European journal of pharmaceutics and biopharmaceutics, 82 (1), 27–35.
  • Jena, S.K., et al., 2017. Potential of amphiphilic graft copolymer α-tocopherol succinate-g-carboxymethyl chitosan in modulating the permeability and anticancer efficacy of tamoxifen. European journal of pharmaceutical sciences, 101, 149–159.
  • Jiang, T., et al., 2018. Enhanced transdermal drug delivery by transfersome-embedded oligopeptide hydrogel for topical chemotherapy of melanoma. ACS nano, 12 (10), 9693–9701.
  • Kateh Shamshiri, M., et al., 2019. Lecithin soybean phospholipid nano‐transfersomes as potential carriers for transdermal delivery of the human growth hormone. Journal of cellular biochemistry, 120 (6), 9023–9033.
  • Liu, J., et al., 2021. Transcriptomic profiling of plaque psoriasis and cutaneous T cell subsets during treatment with secukinumab. JID innovations, 2 (3), 100094.
  • Maheshwari, R.G., et al., 2012. Ethosomes and ultradeformable liposomes for transdermal delivery of clotrimazole: a comparative assessment. Saudi pharmaceutical journal, 20 (2), 161–170.
  • Mahor, S., et al., 2007. Cationic transfersomes based topical genetic vaccine against hepatitis B. International journal of pharmaceutics, 340 (1–2), 13–19.
  • Maul, J.-T., et al., 2021. Topical treatment of psoriasis vulgaris: the Swiss treatment pathway. Dermatology, 237 (2), 166–178.
  • Menter, A., et al., 2019. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. Journal of the American academy of dermatology, 80 (4), 1029–1072.
  • Michalek, I., Loring, B., and John, S., 2017. A systematic review of worldwide epidemiology of psoriasis. Journal of the European academy of dermatology and venereology, 31 (2), 205–212.
  • Mostafa, M., et al., 2018. Optimization and characterization of thymoquinone-loaded liposomes with enhanced topical anti-inflammatory activity. AAPS PharmSciTech, 19, 3490–3500.
  • Mrowietz, U., Elder, J.T., and Barker, J., 2007. The importance of disease associations and concomitant therapy for the long-term management of psoriasis patients. Archives of dermatological research, 298 (7), 309–319.
  • Mueller, W., and Herrmann, B., 1979. Cyclosporin A for psoriasis. New England journal of medicine, 301 (10), 555.
  • Nordin, U.U.M., et al., 2021. Lipid-based nanoparticles for psoriasis treatment: a review on conventional treatments, recent works, and future prospects. RSC advances, 11 (46), 29080–29101.
  • Nussbaum, L., Chen, Y., and Ogg, G., 2021. Role of regulatory T cells in psoriasis pathogenesis and treatment. British journal of dermatology, 184 (1), 14–24.
  • Pandey, S., et al., 2021. A comprehensive review on possibilities of treating psoriasis using dermal cyclosporine. Drug delivery translational research, 12, 1–15.
  • Pradhan, M., et al., 2018. Understanding the prospective of nano-formulations towards the treatment of psoriasis. Biomedicine & pharmacotherapy biomedicine & pharmacotherapie, 107, 447–463.
  • Prinz, J., 2003. The role of T cells in psoriasis. Journal of the European academy of dermatology and venereology, 17 (3), 257–270.
  • Prow, T.W., et al., 2011. Nanoparticles and microparticles for skin drug delivery. Advanced drug delivery reviews, 63 (6), 470–491.
  • Qushawy, M., et al., 2018. Design, optimization and characterization of a transfersomal gel using miconazole nitrate for the treatment of candida skin infections. Pharmaceutics, 10 (1), 26.
  • Roy, P. K., and Datta, A., 2019. Inhibition of excessive keratinocyte growth in psoriasis using drugs cyclosporin and FK506. Mathematical models for therapeutic approaches to control psoriasis. SpringerBriefs in Applied Sciences and Technology. Singapore: Springer.
  • Sathe, P., et al., 2019. Dithranol-loaded nanostructured lipid carrier-based gel ameliorate psoriasis in imiquimod-induced mice psoriatic plaque model. Drug development and industrial pharmacy, 45 (5), 826–838.
  • Silva, L.A.D., et al., 2016. Evaluation of carvedilol compatibility with lipid excipients for the development of lipid-based drug delivery systems. Journal of thermal analysis and calorimetry, 123 (3), 2337–2344.
  • Singh, H.P., et al., 2009. Elastic liposomal formulation for sustained delivery of colchicine: in vitro characterization and in vivo evaluation of anti-gout activity. AAPS journal, 11 (1), 54–64.
  • Takeshita, J., et al., 2017. Psoriasis and comorbid diseases: epidemiology. Journal of the American academy of dermatology, 76 (3), 377–390.
  • Trombino, S., et al., 2019. Solid lipid nanoparticles made of trehalose monooleate for cyclosporin-A topic release. Journal of drug delivery science and technology, 49, 563–569.
  • Trotta, M., et al., 2004. Deformable liposomes for dermal administration of methotrexate. International journal of pharmaceutics, 270 (1–2), 119–125.
  • Yu, Y., et al., 2021. Infliximab modifies regulatory T cells and co-inhibitory receptor expression on circulating T cells in psoriasis. International immunopharmacology, 96, 107722.
  • Zhai, H., and Maibach, H.I.J.S.P, 2001. Effects of skin occlusion on percutaneous absorption: an overview. Skin pharmacology and applied skin physiology, 14 (1), 1–10.
  • Zhang, Y., et al., 2015. Evaluation of transdermal salidroside delivery using niosomes via in vitro cellular uptake. International journal of pharmaceutics, 478 (1), 138–146.
  • Zhang, Y.-T., et al., 2014. Comparison of ethosomes and liposomes for skin delivery of psoralen for psoriasis therapy. International journal of pharmaceutics, 471 (1–2), 449–452.
  • Zhao, Y.-Z., et al., 2013. Selection of high efficient transdermal lipid vesicle for curcumin skin delivery. International journal of pharmaceutics, 454 (1), 302–309.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.